| abstract |
The application provides the use of fucoidan to inhibit the LOX-1 signaling pathway. In particular, the present application relates to the use of a fucosan active substance as a LOX-1 signaling pathway inhibitor or a product that inhibits the LOX-1 signaling pathway, and a fucosan active substance in the preparation of a LOX-1 signaling pathway inhibitor or Use in products for the prevention, adjuvant therapy, and/or treatment of diseases, conditions, or signs associated with LOX-1 overexpression or dysfunction. The application also relates to the use of fucoidan as an inhibitor of the LOX-1 signaling pathway. |